Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46,469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial.
Chen YH, Huang CN, Cho YM, Li P, Gu L, Wang F, Yang J, Wang WQ. Chen YH, et al. Among authors: wang f, wang wq. Diabetes Obes Metab. 2018 Sep;20(9):2121-2130. doi: 10.1111/dom.13340. Epub 2018 Jun 5. Diabetes Obes Metab. 2018. PMID: 29708650 Free PMC article. Clinical Trial.
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial.
Wang W, Nevárez L, Filippova E, Song KH, Tao B, Gu L, Wang F, Li P, Yang J. Wang W, et al. Among authors: wang f. Diabetes Obes Metab. 2019 Feb;21(2):234-243. doi: 10.1111/dom.13506. Epub 2018 Oct 7. Diabetes Obes Metab. 2019. PMID: 30129089 Free PMC article. Clinical Trial.
A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor activity of QL1604, a humanized anti-PD-1 mAb, in patients with advanced or metastatic solid tumors.
Huang Z, Xu Y, Hong W, Gong L, Chen K, Qin J, Xie F, Wang F, Tian X, Meng X, Feng W, Li L, Zhang B, Kang X, Fan Y. Huang Z, et al. Among authors: wang f. Front Immunol. 2023 Oct 23;14:1258573. doi: 10.3389/fimmu.2023.1258573. eCollection 2023. Front Immunol. 2023. PMID: 37936687 Free PMC article. Clinical Trial.
46,469 results
You have reached the last available page of results. Please see the User Guide for more information.